EmendoBio
Latest round
- Series B
Last raised
- Jan 2020
Total raised
- $63M
Investors
- 1
About EmendoBio
EmendoBio Inc.Founded in 2015 and headquartered in New York, US, EmendoBio Inc. operates in the biotechnology sector, creating custom gene editing solutions.EmendoBio specializes in advanced gene editing technologies, primarily focusing on developing novel CRISPR solutions tailored to address complex genetic diseases. Their core offerings include custom-designed nucleases and optimized guide-RNAs that enhance gene editing precision and efficacy. The company's disease-first strategy prioritizes understanding genetic conditions before developing tailored therapies.EmendoBio generates revenue through partnerships with biotechnology and pharmaceutical companies, facilitating collaborations for the development and commercialization of their CRISPR technologies. These partnerships typically involve B2B agreements for custom gene editing solutions tailored to client needs, with structured payments for services, milestone payments, and royalties on developed products.Following the acquisition of EmendoBio Inc. by AnGes, Inc. in November 2020, the company aims to leverage its innovative CRISPR technology to expand its market reach. Future plans include the design and launch of new gene editing products tailored to address evolving challenges in genetic therapy.
Who invested in EmendoBio
1 investor across 1 round
See all investors in EmendoBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 15, 2020
Amount
$63M
Investors
Questions about EmendoBio
Who invested in EmendoBio?
EmendoBio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EmendoBio raised?
EmendoBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did EmendoBio last raise money?
EmendoBio's most recent round on record is a Series B, in Jan 2020.
What does EmendoBio do?
EmendoBio is a biotechnology company.
Where is EmendoBio headquartered?
EmendoBio is headquartered in New York, US.
Which VCs invest in companies like EmendoBio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at EmendoBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like EmendoBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.